找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cell Therapy; Yasuo Ikeda (Professor),Jun-ichi Hata (Professor), Conference proceedings 2000 Springer-Verlag Tokyo 2000 Carcinom.Vivo.bone

[復制鏈接]
樓主: 令人不愉快
11#
發(fā)表于 2025-3-23 13:32:31 | 只看該作者
12#
發(fā)表于 2025-3-23 17:03:10 | 只看該作者
A Novel Acute Promyelocytic Leukemia Model: From Cell to Murine System patients achieve complete remission by the treatment of all-. RA; however, clinical remissions are usually of brief duration, and these patients often develop RA-resistant disease. The mechanisms of RA resistance in APL cells are poorly understood, and most clinical approaches have not been success
13#
發(fā)表于 2025-3-23 18:59:42 | 只看該作者
Phase 1 Trial of Retroviral-Mediated Transfer of the Human MDR-1 in Patients Undergoing High-Dose Ch-sensitive drugs such as the vinca alkaloids, anthracyclines, podophyllotoxins, and taxanes. In this report of a phase 1 clinical study performed at the Columbia-Presbyterian Medical Center, we demonstrate the safety and efficacy of transfer of the human multiple drug resistance (MDR) gene into hema
14#
發(fā)表于 2025-3-24 01:44:25 | 只看該作者
Basic Studies Toward Hematopoietic Stem Cell Gene Therapyare an ideal target for gene therapy. Retroviral vectors are predominantly used for transduction of HSCs, but the gene transfer efficiency is extremely low. Several efforts have been made at achieving clinically relevant gene transfer efficiencies. First, new cytokines such as Flt-3 ligand and throm
15#
發(fā)表于 2025-3-24 03:30:09 | 只看該作者
Ex Vivo Expansion of Hematopoietic Cells neutropenia following transplantation. To date, no clinical studies using ex vivo expanded cells have demonstrated any decrease in the time to neutrophil or platelet recovery, although a number of clinical studies have been performed using a variety of growth factor cocktails and culture conditions
16#
發(fā)表于 2025-3-24 10:15:56 | 只看該作者
17#
發(fā)表于 2025-3-24 13:02:40 | 只看該作者
18#
發(fā)表于 2025-3-24 17:28:30 | 只看該作者
19#
發(fā)表于 2025-3-24 22:44:56 | 只看該作者
20#
發(fā)表于 2025-3-25 01:38:55 | 只看該作者
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-11 08:01
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
施甸县| 永宁县| 舞阳县| 离岛区| 南通市| 水城县| 定日县| 泗洪县| 齐河县| 孝义市| 兰考县| 平山县| 嘉义市| 隆林| 青河县| 郁南县| 济宁市| 新宁县| 嘉定区| 鸡东县| 大厂| 大英县| 绥棱县| 印江| 合水县| 内乡县| 刚察县| 施秉县| 扬州市| 修武县| 巴彦县| 凯里市| 剑河县| 长阳| 华安县| 吉木萨尔县| 巴里| 玉环县| 泸水县| 鄂托克前旗| 红河县|